InMed Pharmaceuticals Inc

InMed Pharmaceuticals is a clinical-stage pharmaceutical company based in Vancouver, British Columbia, focused on developing proprietary small molecule drug candidates targeting the CB1 and CB2 receptors. Its pipeline includes treatments for Alzheimer's disease, age-related macular degeneration, and epidermolysis bullosa, with promising preclinical and clinical data demonstrating multifaceted therapeutic effects.

Through its subsidiary BayMedica, InMed also manufactures a portfolio of premium rare cannabinoids for health and wellness products, ensuring high purity and consistency. The company combines extensive expertise in pharmaceutical research and development with advanced manufacturing capabilities to position itself as a leader in cannabinoid-based therapeutics.

Generated from the website